Avalyn Pharma Funding & Investors
Seattle, WA
Avalyn Pharma Inc. operates as a pharmaceutical company. The Company develops treatments for Idiopathic Pulmonary Fibrosis (IPF).
avalynpharma.comTotal Amount Raised: $336,679,488
Avalyn Pharma Funding Rounds
Series C
$175,000,000
Series C Investors
Eventide FenwayPerceptive AdvisorsSr OneWellington ManagementCatalio Capital ManagementPiper Heartland Healthcare CapitalVida VenturesPivotal bioVenture Partners Investment AdvisorSurveyor CapitalRock Springs CapitalRiverVest Venture PartnersNorwest Venture PartnersF-Prime CapitalNovo HoldingsSeries B
$35,500,000
Series B Investors
Norwest Venture PartnersF-Prime CapitalPivotal bioVenture Partners Investment AdvisorTPG BiotechRiverVest Venture PartnersNovo HoldingsSeries A
$62,000,000
Series A Investors
Andera PartnersF-Prime CapitalNovo HoldingsRiverVest Venture PartnersTPG BiotechSeries A
$62,000,000
Series A Investors
Eight Roads VenturesAndera PartnersRiverVest Venture PartnersTPG BiotechF-Prime CapitalNovo HoldingsEdmond de RothschildSeed
$2,179,480
Funding info provided by Diffbot.